155P - Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC)

Autor: Saavedra Serrano, C., Barquín García, A., Corral de la Fuente, E., Serrano Domingo, J.J., Albarrán Artahona, V., Martin Huertas, R., Gómez Rueda, A., Olmedo García, M.E.
Zdroj: In Annals of Oncology April 2019 30 Supplement 2:ii57-ii58
Databáze: ScienceDirect